// App-Quantinova.ai

: A practical approach to switch from a multiple pill therapeutic strategy to a polypill-based strategy for cardiovascular prevention in patients with hypertension

Researchers

Presenter

  • Coca, Antonio

Principal Investigators

  • Kreutz, Reinhold

  • Manolis, Athanasios J

  • Mancia, Giuseppe

Medical Centers

  • Hypertension and Vascular Risk Unit, Department of Internal Medicine, Hospital Clínic, University of Barcelona, Barcelona, Spain

  • Department of Cardiothoracic Surgery, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

  • Inst. of Clinical Pharmacology and Toxicology, Charité, Berlin, Germany

  • Department of Pathology, Hippokration Hospital, Athens, Greece

  • Policlinico di Monza, Monza, Italy

  • University of Milano-Bicocca, Monza, Italy

Locations

  • Spain

  • Germany

  • Greece

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

  • Hypertension

  • Venous thrombosis

Biomarkers

  • Cancer antigen 15-3

Drug/Treatment

  • Angiotensin II

  • Polypill

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved